Peri-hilar cholangiocarcinoma: results from the UK nationwide CAPBIL study
HPB · 2025-11 · 27 (11) · 1367-1378
DOI: 10.1016/j.hpb.2025.08.003 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift HPB, 2025-11. Verfasst von Jane McClements und 53 weiteren Autor:innen. Beteiligte Einrichtung: Belfast Health and Social Care Trust, Belfast, UK. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Hepatectomy, Klatskin Tumor, Cholangiocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: AstraZeneca AG.
Abstract (Originalsprache)
BACKGROUND: The role of liver transplantation as a treatment option for de novo resectable peri-hilar cholangiocarcinoma (pCCA) is controversial. This study investigated the outcomes following resection of early-stage pCCA in the UK. METHODS: Patients undergoing resection for pCCA between 2014 and 2022 across 22 UK centres were included. Early-stage pCCA was defined as tumour size
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Belfast Health and Social Care Trust, Belfast, UK.
- Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Royal Surrey Hospital, London, UK.
- Royal Free London NHS Foundation Trust, London, UK.
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
- University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Förderung
- AstraZeneca AG
Zitieren
APA
McClements, J., Koh, A., Sellappan, H., Blackburn, L., Brooks, A., Clements, J., Merali, N., Frampton, A., Gulbahar, S., Davidson, B., Almomani, E., Bartlett, D., Papadopoulos, G., Karavias, D., Rowcroft, A., Lucocq, J., Harrison, E. M., Morrison-Jones, V., Welsh, F., …, & UK HPB Research Collaborative Group, United Kingdom (2025). Peri-hilar cholangiocarcinoma: results from the UK nationwide CAPBIL study. HPB, 27(11), 1367-1378. https://doi.org/10.1016/j.hpb.2025.08.003
Vancouver
McClements J, Koh A, Sellappan H, Blackburn L, Brooks A, Clements J, et al. Peri-hilar cholangiocarcinoma: results from the UK nationwide CAPBIL study. HPB. 2025;27(11):1367-1378. doi:10.1016/j.hpb.2025.08.003
BibTeX
@article{McClements2025,
author = {McClements, Jane and Koh, Amanda and Sellappan, Harivinthan and Blackburn, Lauren and Brooks, Adam and Clements, Jake and Merali, Nabeel and Frampton, Adam and Gulbahar, Syeda and Davidson, Brian and Almomani, Eyas and Bartlett, David and Papadopoulos, Georgios and Karavias, Dimitrios and Rowcroft, Alistair and Lucocq, James and Harrison, Ewen M and Morrison-Jones, Victoria and Welsh, Fenella and Pathanki, Adithya and Marangoni, Gabriele and Bruno, Paris and Skipworth, James and Spiers, Harry and Kosmoliaptsis, Vasilis and Gilbert, Timothy and Malik, Hassan and Vijayashanker, Aarathi and Menon, Krishna and Patel, Waqqas and Bekheit, Mohammed and Tanno, Lulu and Silva, Michael and Brown, Christopher and Kumar, Nagappan and Triance, Joel and Shah, Nehal and Alsaoudi, Tareq and Bhardwaj, Neil and Nassar, Hussein and Mownah, Omar and Yeung, Derek and Bhogal, Ricky and Blanco-Colino, Ruth and Farid, Shahid and Aljaberi, Rami and Pandanaboyana, Sanjay and Abdelmohsin, Omar and Aroori, Somaiah and Evans, Daisy and Athwal, Tejinderjit and Lodge, Peter and Gomez, Dhanwant and UK HPB Research Collaborative Group, United Kingdom, UK HPB Research Collaborative Group, United Kingdom},
title = {Peri-hilar cholangiocarcinoma: results from the UK nationwide CAPBIL study},
journal = {HPB},
year = {2025},
volume = {27},
number = {11},
pages = {1367--1378},
doi = {10.1016/j.hpb.2025.08.003}
}
EUVIMED